BCYC
Price
$25.09
Change
-$0.89 (-3.43%)
Updated
Feb 29, 6:59 PM EST
62 days until earnings call
DNLI
Price
$19.78
Change
-$0.43 (-2.13%)
Updated
Feb 29, 6:59 PM EST
62 days until earnings call
Ad is loading...

Analysis and predictions BCYC vs DNLI

Header iconBCYC vs DNLI Comparison
Open Charts BCYC vs DNLIBanner chart's image
Bicycle Therapeutics
Price$25.09
Change-$0.89 (-3.43%)
Volume$87.3K
CapitalizationN/A
Denali Therapeutics
Price$19.78
Change-$0.43 (-2.13%)
Volume$899.78K
CapitalizationN/A
View a ticker or compare two or three
BCYC vs DNLI Comparison Chart

Loading...

BCYCDaily Signal changed days agoGain/Loss if shorted
 
Show more...
DNLIDaily Signal changed days agoGain/Loss if shorted
 
Show more...
VS
BCYC vs. DNLI commentary
Mar 01, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BCYC is a Buy and DNLI is a StrongSell.

COMPARISON
Comparison
Mar 01, 2024
Stock price -- (BCYC: $25.10 vs. DNLI: $19.77)
Brand notoriety: BCYC and DNLI are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: BCYC: 57% vs. DNLI: 92%
Market capitalization -- BCYC: $950.8M vs. DNLI: $2.73B
BCYC [@Biotechnology] is valued at $950.8M. DNLI’s [@Biotechnology] market capitalization is $2.73B. The market cap for tickers in the [@Biotechnology] industry ranges from $541.24B to $0. The average market capitalization across the [@Biotechnology] industry is $2.59B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

BCYC’s FA Score shows that 0 FA rating(s) are green whileDNLI’s FA Score has 0 green FA rating(s).

  • BCYC’s FA Score: 0 green, 5 red.
  • DNLI’s FA Score: 0 green, 5 red.
According to our system of comparison, BCYC is a better buy in the long-term than DNLI.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

BCYC’s TA Score shows that 5 TA indicator(s) are bullish while DNLI’s TA Score has 5 bullish TA indicator(s).

  • BCYC’s TA Score: 5 bullish, 4 bearish.
  • DNLI’s TA Score: 5 bullish, 4 bearish.
According to our system of comparison, both BCYC and DNLI are a good buy in the short-term.

Price Growth

BCYC (@Biotechnology) experienced а +4.67% price change this week, while DNLI (@Biotechnology) price change was +17.47% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +5.64%. For the same industry, the average monthly price growth was +16.56%, and the average quarterly price growth was +43.85%.

Reported Earning Dates

BCYC is expected to report earnings on May 02, 2024.

DNLI is expected to report earnings on May 02, 2024.

Industries' Descriptions

@Biotechnology (+5.64% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
A.I.dvisor published
a Summary for BCYC with price predictions.
OPEN
A.I.dvisor published
a Summary for DNLI with price predictions.
OPEN
FUNDAMENTALS
Fundamentals
DNLI($2.73B) has a higher market cap than BCYC($951M). BCYC YTD gains are higher at: 38.827 vs. DNLI (-7.875). DNLI has higher annual earnings (EBITDA): -150.83M vs. BCYC (-169.4M). DNLI has more cash in the bank: 1.11B vs. BCYC (526M). BCYC has less debt than DNLI: BCYC (45M) vs DNLI (53.9M). DNLI has higher revenues than BCYC: DNLI (341M) vs BCYC (27M).
BCYCDNLIBCYC / DNLI
Capitalization951M2.73B35%
EBITDA-169.4M-150.83M112%
Gain YTD38.827-7.875-493%
P/E RatioN/A62.89-
Revenue27M341M8%
Total Cash526M1.11B47%
Total Debt45M53.9M83%
FUNDAMENTALS RATINGS
DNLI: Fundamental Ratings
DNLI
OUTLOOK RATING
1..100
11
VALUATION
overvalued / fair valued / undervalued
1..100
81
Overvalued
PROFIT vs RISK RATING
1..100
95
SMR RATING
1..100
90
PRICE GROWTH RATING
1..100
51
P/E GROWTH RATING
1..100
96
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
BCYCDNLI
RSI
ODDS (%)
Bearish Trend 1 day ago
90%
Bearish Trend 1 day ago
82%
Stochastic
ODDS (%)
Bearish Trend 1 day ago
89%
Bullish Trend 1 day ago
85%
Momentum
ODDS (%)
Bullish Trend 1 day ago
85%
Bullish Trend 1 day ago
80%
MACD
ODDS (%)
Bullish Trend 1 day ago
78%
Bullish Trend 1 day ago
79%
TrendWeek
ODDS (%)
Bullish Trend 1 day ago
86%
Bullish Trend 1 day ago
80%
TrendMonth
ODDS (%)
Bullish Trend 1 day ago
89%
Bullish Trend 1 day ago
77%
Advances
ODDS (%)
Bullish Trend 3 days ago
86%
Bullish Trend 7 days ago
79%
Declines
ODDS (%)
Bearish Trend 1 day ago
84%
Bearish Trend 1 day ago
82%
BollingerBands
ODDS (%)
Bearish Trend 1 day ago
87%
Bearish Trend 1 day ago
81%
Aroon
ODDS (%)
N/A
Bearish Trend 1 day ago
83%
View a ticker or compare two or three
Ad is loading...
BCYCDaily Signal changed days agoGain/Loss if shorted
 
Show more...
DNLIDaily Signal changed days agoGain/Loss if shorted
 
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
RMQHX511.529.12
+1.82%
Rydex Monthly Rbl NASDAQ-100® 2x Strt H
FLCKX38.610.34
+0.89%
Fidelity Leveraged Company Stock K
JDVVX23.440.10
+0.43%
JHancock Disciplined Value R5
WESWX11.200.03
+0.27%
TETON Westwood Equity AAA
MLXAX21.30N/A
N/A
Catalyst Energy Infrastructure A

BCYC and

Correlation & Price change

A.I.dvisor indicates that over the last year, BCYC has been loosely correlated with PHIO. These tickers have moved in lockstep 41% of the time. This A.I.-generated data suggests there is some statistical probability that if BCYC jumps, then PHIO could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To BCYC
1D Price
Change %
BCYC100%
-3.39%
PHIO - BCYC
41%
Loosely correlated
+9.74%
MLTX - BCYC
39%
Loosely correlated
-15.07%
ABUS - BCYC
37%
Loosely correlated
-2.60%
ORMP - BCYC
35%
Loosely correlated
-3.81%
SAGE - BCYC
34%
Loosely correlated
-4.72%
More

DNLI and

Correlation & Price change

A.I.dvisor indicates that over the last year, DNLI has been closely correlated with BEAM. These tickers have moved in lockstep 68% of the time. This A.I.-generated data suggests there is a high statistical probability that if DNLI jumps, then BEAM could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To DNLI
1D Price
Change %
DNLI100%
-2.18%
BEAM - DNLI
68%
Closely correlated
-9.45%
NTLA - DNLI
68%
Closely correlated
-2.07%
JANX - DNLI
62%
Loosely correlated
+3.77%
VCYT - DNLI
61%
Loosely correlated
-0.93%
EDIT - DNLI
59%
Loosely correlated
-9.12%
More